Vanguard Global Advisers
IRON icon

Vanguard Global Advisers’s Disc Medicine IRON Stock Holding History

Vanguard Global Advisers’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$848K Sell
11,597
-919
-7% -$63.1K ﹤0.01% 1839
2026
Q1 		$800K Buy
+12,516
New +$869K ﹤0.01% 1776

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Global Advisers's IRON Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Disc Medicine (IRON) stake by 7.3% in Q2 2026, selling an estimated $63.1K and leaving 11,597 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Vanguard Global Advisers first reported a position in IRON in Q1 2026 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Vanguard Global Advisers held 11,597 shares of Disc Medicine worth $848K as of Q2 2026.
  • Vanguard Global Advisers sold 919 Disc Medicine shares in Q2 2026, an estimated $63.1K.
  • Disc Medicine made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1839 holding.
  • Vanguard Global Advisers first reported a position in Disc Medicine in Q1 2026 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.